Feb 10, 2023 | Business News, Investor News
First major milestone reached for Reacta Healthcare £1m Innovate UK funded project Posted on February 10, 2023 Reacta Healthcare is helping combat food allergies amongst paediatrics, addressing the unmet need for greater research and clinical practice in children to...
Jan 20, 2023 | Appointments, Business News
Senior hire to cement 2023 growth plans at Reacta Healthcare Posted on January 20, 2023 Reacta Healthcare has appointed a new quality control manager to further expand and develop its quality function. The leadership post will ensure delivery of the company’s growth...
Dec 9, 2022 | Business News, Industry Talk
My time at MEDICA 2022 Posted on December 9, 2022 By Dr Martin Wickham, Chief Commercial Officer, Reacta Healthcare Last month I had the privilege of not only attending but presenting at MEDICA, the world’s largest event for the medical sector. It’s so inspiring...
Sep 12, 2022 | Business News, Investor News
Development Bank of Wales ramping up tech equity deals since the lockdown Posted on September 12, 2022 The Development Bank of Wales has invested £2.4m of equity into ten of Wales’ most promising tech-focused start-ups over a ten week period since the pandemic...
Aug 8, 2022 | Business News, Milestones
Reacta Healthcare secures first US patent Posted on August 8, 2022 The patent has been granted for challenge meals, which are used in oral food challenges (OFCs). Unique to the Reacta formulation is Reacta’s ability to create a non-allergen formulation that is...
Apr 27, 2022 | Business News, Investor News
Reacta Healthcare Awarded Major Biomedical Catalyst Grant to develop Paediatric Food allergy diagnostics Posted on April 27, 2022 The £1 million grant will support the development of the first Oral Food Challenges (OFCs) for paediatric patients to diagnose...
